Get the Stockscreener App
82.06
0.71%
-0.59
After Hours:
82.06
Nuvalent Inc stock is traded at $82.06, with a volume of 230.71K.
It is down -0.71% in the last 24 hours and down -14.79% over the past month.
Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.
See More
Previous Close:
$82.65
Open:
$81.94
24h Volume:
230.71K
Relative Volume:
0.54
Market Cap:
$5.85B
Revenue:
-
Net Income/Loss:
$-224.29M
P/E Ratio:
-44.36
EPS:
-1.85
Net Cash Flow:
$-153.27M
1W Performance:
-3.05%
1M Performance:
-14.79%
6M Performance:
+4.16%
1Y Performance:
+10.44%
1-Day Range:
$81.51
$83.11
1-Week Range:
$81.11
$87.31
52-Week Range:
$61.80
$113.51
Nuvalent Inc Stock (NUVL) Company Profile
Name
Nuvalent Inc
Sector
Industry
Phone
508-446-2272
Address
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Compare NUVL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
82.06 | 5.85B | 0 | -224.29M | -153.27M | -3.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
410.65 | 105.21B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.68 | 78.48B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
632.04 | 37.55B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.50 | 31.19B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.77 | 27.43B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-24-24 | Initiated | UBS | Neutral |
| Aug-29-24 | Initiated | Barclays | Overweight |
| Apr-17-24 | Initiated | Jefferies | Buy |
| Apr-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-28-24 | Resumed | Guggenheim | Buy |
| Feb-23-24 | Initiated | Robert W. Baird | Outperform |
| Sep-27-23 | Initiated | Stifel | Buy |
| Aug-08-23 | Initiated | SVB Securities | Market Perform |
| Jul-24-23 | Initiated | Guggenheim | Buy |
| Jan-18-23 | Initiated | Wedbush | Outperform |
| Jun-24-22 | Initiated | BMO Capital Markets | Outperform |
View All
Nuvalent Inc Stock (NUVL) Latest News
Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Franklin Resources Inc. Sells 35,063 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Geode Capital Management LLC Increases Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Lelezard
Nuvalent, Inc. (NASDAQ:NUVL) Shares Acquired by Barclays PLC - MarketBeat
Pharma Trial Consultant To Pay SEC $3M Over Insider Trading - Law360
Nuvalent, Inc. (NASDAQ:NUVL) CEO Sells $2,338,470.00 in Stock - MarketBeat
Nuvalent CEO Porter James Richard sells $2.34 million in stock By Investing.com - Investing.com South Africa
Nuvalent CEO Porter James Richard sells $2.34 million in stock - Investing.com India
Nuvalent's SWOT analysis: precision oncology stock poised for growth By Investing.com - Investing.com Canada
Nuvalent's SWOT analysis: precision oncology stock poised for growth - Investing.com
Lord Abbett & CO. LLC Raises Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
(NUVL) Investment Report - Stock Traders Daily
7,417 Shares in Nuvalent, Inc. (NASDAQ:NUVL) Purchased by Virtu Financial LLC - MarketBeat
State Street Corp Sells 82,941 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent director Andrew Hack sells $110 million in stock By Investing.com - Investing.com Australia
Nuvalent director Andrew Hack sells $110 million in stock - Investing.com India
Nuvalent Announces Closing of Upsized Public Offering of Common Stock - The Eastern Progress Online
NuCana (NASDAQ:NCNA) and Nuvalent (NASDAQ:NUVL) Head to Head Review - Defense World
12,264 Shares in Nuvalent, Inc. (NASDAQ:NUVL) Purchased by Y Intercept Hong Kong Ltd - MarketBeat
Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Eastern Progress Online
Nuvalent to Present at the 42nd Annual J.P. Morgan Healthcare Co - GuruFocus.com
Nuvalent Announces Pricing of Upsized Public Offering of Common Stock - The Eastern Progress Online
Nuvalent, Inc. (NASDAQ:NUVL) Shares Purchased by Wellington Management Group LLP - MarketBeat
Nuvalent appoints new independent director - Investing.com India
Nuvalent appoints new independent director By Investing.com - Investing.com Canada
Nuvalent Elects Grant Bogle as Independent Director - TipRanks
Nuvalent Appoints Grant Bogle to Board of Directors - citybiz
Nuvalent : RESTRICTED STOCK UNIT AWARD AGREEMENT FOR COMPANY EMPLOYEES UNDER THE NUVALENT, INC. 2021 STOCK OPTION AND INCENTIVE PLAN Form 8 K - Marketscreener.com
Two Sigma Advisers LP Sells 9,000 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Verition Fund Management LLC Invests $1.07 Million in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent Announces Public Offering of Common Stock - The Eastern Progress Online
Nuvalent: Steps Toward That Favorable Entry Point - Seeking Alpha
Edgestream Partners L.P. Has $289,000 Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Shares Bought by The Manufacturers Life Insurance Company - MarketBeat
Nuvalent's SWOT analysis: promising pipeline drives stock outlook By Investing.com - Investing.com UK
(NUVL) Trading Signals - Stock Traders Daily
RA Capital Management L.P. Increases Stake in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent CFO Alexandra Balcom sells $957,940 in stock By Investing.com - Investing.com Australia
Parkman Healthcare Partners LLC Has $2.39 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Erste Asset Management GmbH Invests $1.14 Million in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Walleye Capital LLC Buys New Position in Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Charles Schwab Investment Management Inc. Acquires 50,536 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat
Nuvalent Inc Stock (NUVL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nuvalent Inc Stock (NUVL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Balcom Alexandra | Chief Financial Officer |
Dec 17 '24 |
Option Exercise |
4.88 |
13,700 |
66,923 |
47,000 |
| Pelish Henry E. | Chief Scientific Officer |
Dec 16 '24 |
Option Exercise |
0.75 |
10,414 |
7,759 |
43,714 |
| Porter James Richard | President and CEO |
Dec 16 '24 |
Option Exercise |
27.85 |
27,000 |
751,950 |
215,113 |
| Porter James Richard | President and CEO |
Dec 16 '24 |
Sale |
86.61 |
27,000 |
2,338,436 |
188,113 |
| Hack Andrew A. F. | Director |
Dec 11 '24 |
Sale |
88.00 |
1,250,000 |
110,000,000 |
1,447,267 |
0.50%
1.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):